← Back to Search

Navigator Guidance for Hearing Loss (CHHIRP Trial)

N/A

Waitlist Available

Led By Matthew L Bush, MD, PhD

Research Sponsored by Matthew Bush, MD

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months. (this is the amount of time from an abnormal screen at birth to an expected follow-up at a clinic or hospital.)

Awards & highlights

CHHIRP Trial Summary

This trial is testing whether or not a patient navigator can help children with hearing loss receive timely care. The hypothesis is that the navigator will improve compliance with appointments and expand parental knowledge.

Who is the study for?

This trial is for infants who failed a hearing screening in one or both ears before leaving the hospital after birth, and are referred for follow-up tests at specific clinics. It's also for parents who speak English or can use phone interpreting services. Families must live in Kentucky and not plan to move within three months.Check my eligibility

What is being tested?

The study is testing whether having a patient navigator - someone to support, educate, and guide families - helps children with congenital hearing loss get their necessary hearing tests faster, improves appointment attendance, and increases parental knowledge about the condition.See study design

What are the potential side effects?

Since this intervention involves guidance and support rather than medical treatment, there are no direct physical side effects. However, participants may experience varying levels of emotional or social impact due to the involvement.

CHHIRP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months. (this is the amount of time from an abnormal screen at birth to an expected follow-up at a clinic or hospital.)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months. (this is the amount of time from an abnormal screen at birth to an expected follow-up at a clinic or hospital.)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months. (this is the amount of time from an abnormal screen at birth to an expected follow-up at a clinic or hospital.) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants who do not receive diagnostic audiological testing (Aim 1)

CHHIRP Trial Design

2Treatment groups

Active Control

Group I: Navigator ArmActive Control1 Intervention

Examination of adherence to follow-up with a navigator.

Group II: Non-Intervention ArmActive Control1 Intervention

Examination of adherence to follow-up without a navigator.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Matthew Bush, MDLead Sponsor

3 Previous Clinical Trials

619 Total Patients Enrolled

1 Trials studying Congenital Hearing Loss

106 Patients Enrolled for Congenital Hearing Loss

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH

328 Previous Clinical Trials

178,089 Total Patients Enrolled

1 Trials studying Congenital Hearing Loss

106 Patients Enrolled for Congenital Hearing Loss

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,363 Total Patients Enrolled

1 Trials studying Congenital Hearing Loss

106 Patients Enrolled for Congenital Hearing Loss

Media Library

Navigator Guidance Clinical Trial Eligibility Overview. Trial Name: NCT03875339 — N/A

Congenital Hearing Loss Research Study Groups: Navigator Arm, Non-Intervention Arm

Congenital Hearing Loss Clinical Trial 2023: Navigator Guidance Highlights & Side Effects. Trial Name: NCT03875339 — N/A

Navigator Guidance 2023 Treatment Timeline for Medical Study. Trial Name: NCT03875339 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged less than seventy five years old allowed to participate in this research?

"This trial is available to any patient between 0 and 99 years of age. Separately, there are 49 clinical trials for minors and 123 studies dedicated to seniors beyond the retirement age."

Answered by AI

Are there any openings left in this research trial?

"Unfortunately, the data on clinicaltrials.gov demonstrates that this study is not presently accepting new patients. This experiment was first posted on August 1st 2019 and edited most recently in February of 2022. Despite no longer recruiting for itself, there are still 155 other medical studies actively searching for participants as we speak"

Answered by AI

Who is eligible for participation in this clinical experiment?

"This clinical trial is suitable for individuals aged 0 to 99 that have been diagnosed with hearing loss. There are presently 2240 slots available for participants."

Answered by AI

Recent research and studies

BMJ OpenJournal

Communities Helping the Hearing of Infants by Reaching Parents (CHHIRP) Through Patient Navigation: A Hybrid Implementation Effectiveness Stepped Wedge Trial Protocol

Bush, Matthew, Miranda Hatfield, Marissa Schuh, Beverly Balasuriya, Anthony Mahairas, Julie Jacobs, Christina Studts, et al.. 2022. “Communities Helping the Hearing of Infants by Reaching Parents (CHHIRP) Through Patient Navigation: A Hybrid Implementation Effectiveness Stepped Wedge Trial Protocol”. BMJ Open. BMJ. doi:10.1136/bmjopen-2021-054548.

clinicaltrials.govStudy

Communities Helping the Hearing of Infants by Reaching Parents

Matthew Bush, MD 2021. "Communities Helping the Hearing of Infants by Reaching Parents". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03875339.